Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05130788Completed
Randomised, open-label trial in Tobacco Use Disorder (TUD) (3 arms), sponsored by NYU Langone Health. Primary endpoints: Number of Participants Who Respond to Daily Text Questions at 6 weeks, Number of Participants Who Asked Self-Composed Questions at 6 weeks and 2 more. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05130788.